ABIONYX Pharma SA (EPA:ABNX)

ABIONYX Pharma Revenue

In the year 2025, ABIONYX Pharma had annual revenue of 4.06M EUR, down -10.72%. ABIONYX Pharma had revenue of 1.94M in the half year ending December 31, 2025, a decrease of -22.61%.

• Revenue: 4.06M
• Revenue Growth: -10.72%
• P/S Ratio: 24.32
• Revenue / Employee: 82.92K
• Employees: 51
• Market Cap: 98.82M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.06M	-488.00K	-10.72%
Dec 31, 2024	4.55M	-89.00K	-1.92%
Dec 31, 2023	4.64M	-612.00K	-11.65%
Dec 31, 2022	5.25M	4.58M	678.07%
Dec 31, 2021	675.00K	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 2, 2026

Data Sources Report a data error